Back to search
FDAFDA · Food and drugs·Recall number D-0006-2022

Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07.

Published October 20, 2021 · Recall initiated: September 27, 2021

Summary

FDA records drug Class II recall D-0006-2022, published October 20, 2021 and initiated September 27, 2021. Recalling firm: Strides Pharma Inc.; Status: Terminated; Reported quantity: 1813 bottles; Lot: Lot 7240840A, exp. 12/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if POTASSIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
POTASSIUM CHLORIDE
Manufacturer
Strides Pharma Inc.
Distributor
Nationwide
UPC
0364380860068
Lot
Lot 7240840A, exp. 12/31/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07. recalled?

Yes. FDA published recall D-0006-2022 on October 20, 2021. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: POTASSIUM CHLORIDE. UPC: 0364380860068.